| Oct 1 |
Codexis licenses Genomics Life Science enzyme portfolio to Alphazyme LLC
|
| Oct 1 |
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
|
| Sep 20 |
Opaleye Management Inc. Increases Stake in Codexis Inc.
|
| Sep 7 |
Pleasing Signs As A Number Of Insiders Buy Codexis Stock
|
| Sep 3 |
Codexis to Participate in Upcoming Healthcare Conferences
|
| Aug 20 |
Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting
|
| Aug 16 |
Codexis Announces New Employment Inducement Grants
|
| Aug 15 |
Codexis Publishes FY2023 Sustainability Disclosures
|
| Aug 11 |
Codexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.83
|
| Aug 10 |
Codexis Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
